NASDAQ-GS · traded in Congress
Praxis Precision Medicines, PRAX
$285.93 -2.69 (-0.93%) Oct 30, 2026
Chart
Earnings
Praxis Precision Medicines reports Monday, November 9, before the open.
Analyst ratings
- 19 buy
- 1 hold
- 1 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $0M | - | $-89M | - | |
| $0M | - | $-74M | - | |
| $0M | - | $-71M | - | |
| $0M | - | $-69M | - |
New SEC filings
- SCHEDULE 13G/A SCHEDULE 13G/A filed Nov 5, 2026
All PRAX filings on SEC EDGAR ›
Congress trades in PRAX
Members of Congress disclosed 2 transactions in PRAX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/29/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
| 07/30/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/4/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
